Raymond DuBois to Erlotinib Hydrochloride
This is a "connection" page, showing publications Raymond DuBois has written about Erlotinib Hydrochloride.
Connection Strength
0.076
-
Targeting cyclooxygenase-2 and the epidermal growth factor receptor for the prevention and treatment of intestinal cancer. Cancer Res. 2007 Oct 01; 67(19):9380-8.
Score: 0.076
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.